{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:40:51Z","timestamp":1792269651667,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,16]]},"DOI":"10.7759\/cureus.114586","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:50:51Z","timestamp":1786866651000},"source":"Crossref","is-referenced-by-count":1,"title":["Refractory Amiodarone-Induced Thyrotoxicosis Requiring the Consideration of Thyroidectomy: A Case Report and Review of Management Challenges"],"prefix":"10.7759","author":[{"given":"Hishaam A","family":"Yunas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshey","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khine Wut Yee","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehr B","family":"Syeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena L","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018, 7:55-66. 10.1159\/000486957","journal-title":"Eur Thyroid J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practical guidelines for clinicians who treat patients with amiodarone","volume":"160","author":"Goldschlager N","year":"2000","unstructured":"Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Arch Intern Med. 2000, 160:1741-8. 10.1001\/archinte.160.12.1741","journal-title":"Arch Intern Med"},{"key":"ref3","article-title":"Amiodarone induced thyrotoxicosis","author":"Macchia PE","year":"2000","unstructured":"Macchia PE, Feingold KR. Amiodarone induced thyrotoxicosis. Endotext [Internet]. Feingold KR, Adler RA, Ahmed SF, et al. (ed): MDText.com, Inc., South Dartmouth (MA); 2000."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","author":"Trip MD","year":"1991","unstructured":"Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991, 91:507-11. 10.1016\/0002-9343(91)90187-3","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi F","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010, 95:2529-35. 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63858","article-title":"A case of amiodarone-induced thyrotoxicosis presenting with methimazole-induced agranulocytosis","volume":"16","author":"Meda N","year":"2024","unstructured":"Meda N, Saad-Omer S, Matos M, Kinaan M. A case of amiodarone-induced thyrotoxicosis presenting with methimazole-induced agranulocytosis. Cureus. 2024, 16:e63858. 10.7759\/cureus.63858","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","author":"Bogazzi F","year":"2011","unstructured":"Bogazzi F, Bartalena L, Tomisti L, Rossi G, Brogioni S, Martino E. Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study. J Clin Endocrinol Metab. 2011, 96:3374-80. 10.1210\/jc.2011-1678","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003666","article-title":"Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors","volume":"11","author":"Chow E","year":"2023","unstructured":"Chow E, Clement S, Garg R. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2023, 11:e003666. 10.1136\/bmjdrc-2023-003666","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0046","article-title":"Insulin action in hyperthyroidism: a focus on muscle and adipose tissue","volume":"31","author":"Mitrou P","year":"2010","unstructured":"Mitrou P, Raptis SA, Dimitriadis G. Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocr Rev. 2010, 31:663-79. 10.1210\/er.2009-0046","journal-title":"Endocr Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-023-01393-6","article-title":"Practical guide to glucocorticoid induced hyperglycaemia and diabetes","volume":"14","author":"Barker HL","year":"2023","unstructured":"Barker HL, Morrison D, Llano A, Sainsbury CA, Jones GC. Practical guide to glucocorticoid induced hyperglycaemia and diabetes. Diabetes Ther. 2023, 14:937-45. 10.1007\/s13300-023-01393-6","journal-title":"Diabetes Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2024.01.006","article-title":"Amiodarone-induced thyrotoxicosis: should surgery be considered?","volume":"85","author":"Frey S","year":"2024","unstructured":"Frey S, Caillard C, Mahot P, Drui D, Miralli\u00e9 E. Amiodarone-induced thyrotoxicosis: should surgery be considered?. Ann Endocrinol (Paris). 2024, 85:136-41. 10.1016\/j.ando.2024.01.006","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00482","article-title":"Management of amiodarone-induced thyrotoxicosis at a cardiac transplantation centre","volume":"9","author":"Isaacs M","year":"2018","unstructured":"Isaacs M, Costin M, Bova R, Barrett HL, Heffernan D, Samaras K, Greenfield JR. Management of amiodarone-induced thyrotoxicosis at a cardiac transplantation centre. Front Endocrinol (Lausanne). 2018, 9:482. 10.3389\/fendo.2018.00482","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes SA","year":"2012","unstructured":"Eskes SA, Endert E, Fliers E, Geskus RB, Dullaart RP, Links TP, Wiersinga WM. Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J Clin Endocrinol Metab. 2012, 97:499-506. 10.1210\/jc.2011-2390","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00259","article-title":"Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience","volume":"2","author":"Kotwal A","year":"2018","unstructured":"Kotwal A, Clark J, Lyden M, McKenzie T, Thompson G, Stan MN. Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience. J Endocr Soc. 2018, 2:1226-35. 10.1210\/js.2018-00259","journal-title":"J Endocr Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/509071-refractory-amiodarone-induced-thyrotoxicosis-requiring-the-consideration-of-thyroidectomy-a-case-report-and-review-of-management-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:50:52Z","timestamp":1786866652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/509071-refractory-amiodarone-induced-thyrotoxicosis-requiring-the-consideration-of-thyroidectomy-a-case-report-and-review-of-management-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.114586","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}